Auteurs
Paul England

Dr Paul England

Senior professional support lawyer

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More
Auteurs
Paul England

Dr Paul England

Senior professional support lawyer

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

18 avril 2019

Answering one question and raising others – the CJEU on SPCs for new formulations

This month on Synapse

Answering one question and raising others - the CJEU on SPCs for new formulations

Anja Lunze explains the latest ruling of the CJEU on SPCs, concerning whether new formulations of an active ingredient can be protected.

Territorial Licensing

We explore the practice of geographical licensing, by which the owner of the rights to a product grants to a licensee the exclusive right to develop and/or commercialise the product in a specific country or territory only.

The UK Supreme Court rules on inventive step

Paul England explains the meaning of the ruling on inventive step in the UK Supreme Court decision Actavis v ICOS

Judicial review of marketing authorisation refused

Angus Milne reviews the decision by the UK Administrative Court to refuse a judicial review of the grant of a marketing authorisation for a generic medicinal product, DexEP.

Brexit update – 'Grandfathering' marketing authorisations

Paul England provides the latest update on the date of Brexit and guidance from the MHRA and PMCPA on 'grandfathering'.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Sciences de la vie et Santé

Synapse - January 2020

16 janvier 2020

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Synapse - December 2019

19 décembre 2019

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Synapse - November 2019

26 novembre 2019

par Verena Bertram et Dr Paul England

Cliquer ici pour en savoir plus